Pexiganan is a broad-spectrum topical antimicrobial agent used for the treatment of infections associated with diabetic foot ulcers; it exhibits potent activity against over 3,000 microbial isolates, including Gram-positive bacteria, Gram-negative bacteria, anaerobes, amoebae, fungi, and parasites; due to its unique mechanism of action—disrupting microbial cell membranes rather than targeting specific bacterial proteins—it holds promise as a next-generation antimicrobial agent.